These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3108103)

  • 1. Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus.
    Small M; Douglas JT; Lowe GD; MacCuish AC; Forbes CD
    Haemostasis; 1986; 16(6):417-23. PubMed ID: 3108103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet and coagulation factors in proliferative diabetic retinopathy.
    Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
    J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III.
    Baruch D; Lindhout T; Wagenvoord R; Hemker HC
    Haemostasis; 1986; 16(2):71-81. PubMed ID: 3086193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects.
    Yudkin JS; Panahloo A; Stehouwer C; Emeis JJ; Bulmer K; Mohamed-Ali V; Denver AE
    Diabetologia; 2000 Sep; 43(9):1099-106. PubMed ID: 11043855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy.
    Standl E; Baumgartl HJ; Füchtenbusch M; Stemplinger J
    Diabetes Obes Metab; 1999 Jul; 1(4):215-20. PubMed ID: 11228756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
    Rosove MH; Frank HJ; Harwig SS
    Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III activity and concentration in diabetes mellitus.
    Patrassi GM; Picchinenna R; Vettor R; Cappellato G; Coccarielli D; Girolami A
    Thromb Haemost; 1985 Aug; 54(2):415-7. PubMed ID: 3936213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of diet and insulin therapy on coagulation factor VII, blood viscosity, and platelet release proteins in diabetic patients with secondary sulphonylurea failure.
    Jennings AM; Ford I; Murdoch S; Greaves M; Preston FE; Ward JD
    Diabet Med; 1991 May; 8(4):346-53. PubMed ID: 1830258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.
    Landstedt-Hallin L; Arner P; Lins PE; Bolinder J; Olsen H; Groop L
    Diabet Med; 1999 Oct; 16(10):827-34. PubMed ID: 10547209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of insulin-induced hypoglycaemia on factor VIII:C concentrations and thrombin activity in subjects with type 1 (insulin-dependent) diabetes.
    Ibbotson SH; Catto A; Davies JA; Grant PJ
    Thromb Haemost; 1995 Feb; 73(2):243-6. PubMed ID: 7792737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic responsiveness to long-term insulin plus sulphonylurea therapy as assessed by sulphonylurea withdrawal.
    Nybäck-Nakell A; Adamson U; Lins PE; Landstedt-Hallin L
    Diabet Med; 2007 Dec; 24(12):1424-9. PubMed ID: 17976204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
    Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
    Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin.
    Gregorio F; Ambrosi F; Manfrini S; Velussi M; Carle F; Testa R; Merante D; Filipponi P
    Diabet Med; 1999 Dec; 16(12):1016-24. PubMed ID: 10656230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of short term intensive insulin therapy in non-insulin-dependent diabetics who had failed on sulphonylurea therapy.
    Samanta A; Burden AC; Jones GR; Clarkson L
    Diabetes Res; 1986 Jun; 3(5):269-71. PubMed ID: 3527524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes.
    Aso Y; Okumura K; Yoshida N; Tayama K; Kanda T; Kobayashi I; Takemura Y; Inukai T
    Diabet Med; 2003 Nov; 20(11):930-4. PubMed ID: 14632719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus.
    Reaven GM; Fraze E; Chen NY; Hollenbeck C; Chen YD
    Horm Metab Res; 1989 Mar; 21(3):132-6. PubMed ID: 2663691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes.
    Aoki I; Shimoyama K; Aoki N; Homori M; Yanagisawa A; Nakahara K; Kawai Y; Kitamura SI; Ishikawa K
    J Am Coll Cardiol; 1996 Mar; 27(3):560-6. PubMed ID: 8606265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.